Crescent Capital BDC, Inc. (NASDAQ:CCAP) Short Interest Update

Crescent Capital BDC, Inc. (NASDAQ:CCAP) was the recipient of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 103,400 shares, an increase of 21.2% from the February 13th total of 85,300 shares. Based on an average trading volume of 118,900 shares, the short-interest ratio is presently 0.9 days. Currently, 0.3% of the shares of the stock are sold short.

Analysts Set New Price Targets

A number of research firms recently issued reports on CCAP. Keefe, Bruyette & Woods lifted their target price on Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a report on Monday, November 25th. Wells Fargo & Company lowered their target price on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Friday, February 21st. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.20.

Hedge Funds Weigh In On Crescent Capital BDC

Several institutional investors and hedge funds have recently bought and sold shares of the business. Montag A & Associates Inc. purchased a new stake in shares of Crescent Capital BDC in the fourth quarter worth approximately $35,000. C M Bidwell & Associates Ltd. purchased a new position in Crescent Capital BDC during the fourth quarter valued at approximately $39,000. Aquatic Capital Management LLC purchased a new position in Crescent Capital BDC during the fourth quarter valued at approximately $129,000. Generation Capital Management LLC purchased a new position in Crescent Capital BDC during the fourth quarter valued at approximately $192,000. Finally, Dynamic Technology Lab Private Ltd purchased a new position in Crescent Capital BDC during the fourth quarter valued at approximately $218,000. Hedge funds and other institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC Trading Down 0.0 %

Shares of CCAP stock traded down $0.01 during trading hours on Wednesday, reaching $17.54. 52,327 shares of the stock traded hands, compared to its average volume of 134,026. The company has a quick ratio of 1.26, a current ratio of 1.32 and a debt-to-equity ratio of 1.18. The firm has a market capitalization of $649.88 million, a PE ratio of 8.83 and a beta of 0.82. Crescent Capital BDC has a 1-year low of $16.81 and a 1-year high of $20.19. The business has a fifty day moving average price of $18.80 and a 200 day moving average price of $18.82.

Crescent Capital BDC (NASDAQ:CCAP) last announced its earnings results on Wednesday, February 19th. The company reported $0.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.56 by ($0.01). The firm had revenue of $46.40 million for the quarter, compared to analyst estimates of $47.27 million. Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. On average, equities research analysts forecast that Crescent Capital BDC will post 2.09 EPS for the current year.

Crescent Capital BDC Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were given a dividend of $0.05 per share. The ex-dividend date was Friday, February 28th. Crescent Capital BDC’s payout ratio is presently 84.42%.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.